ClinicalTrials.Veeva

Menu

Correlation of Optic Disk Morphology and Ocular Perfusion Parameters in Patients With Primary Open Angle Glaucoma

Medical University of Vienna logo

Medical University of Vienna

Status

Completed

Conditions

Primary Open Angle Glaucoma

Treatments

Procedure: ocular blood flow measurement

Study type

Observational

Funder types

Other

Identifiers

NCT00803504
OPHT-120905

Details and patient eligibility

About

Glaucoma is one of the most common causes of blindness in the industrialized nations. For a long time glaucoma has been defined as a disease in which high intraocular pressure (IOP) leads to irreversible optic disc damage and subsequent visual field loss. However, recent investigations show that IOP is not the only factor that is involved in the glaucomatous process leading to retinal ganglion cell death. The role of vascular factors in the pathogenesis of glaucoma has recently received much attention based on animal experiments and epidemiological studies. It is, however, assumed that vascular factors do not contribute to same degree in all glaucoma patients. Generally, it is believed that a vascular component is more important in normal tension glaucoma patients and patients with underlying cardiovascular disease. Little is, however, known about a potential association between optic nerve head morphology and ocular perfusion in POAG patients. The current study seeks to gain insight into this association by assessing ocular blood flow parameters with a number of noninvasive technologies.

Enrollment

103 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men and women over 18 years
  • Unilateral or bilateral primary open angle glaucoma
  • At least 3 reliable visual field tests showing CPSD >= 2.0 in the eye that will be studied

Exclusion criteria

  • History of acute angle closure
  • Closed or barely open anterior chamber angle
  • Standard deviation of visual field testing > 10
  • Intraocular surgery or argon laser trabeculoplasty within the last six months
  • Ocular inflammation or infection within the last three months
  • Topical or systemically/oral therapy with steroids

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems